SCI
ABBV icon

Stableford Capital II’s AbbVie ABBV Stock Holding History

Stableford Capital II’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
4,031
-243
-6% -$52.3K 0.35% 79
2026
Q1 		$930K Buy
4,274
+110
+3% +$24.4K 0.35% 90
2025
Q4 		$951K Sell
4,164
-129
-3% -$29.4K 0.34% 97
2025
Q3 		$994K Sell
4,293
-836
-16% -$170K 0.36% 87
2025
Q2 		$976K Buy
5,129
+594
+13% +$110K 0.37% 80
2025
Q1 		$785K Sell
4,535
-376
-8% -$73.1K 0.33% 84
2024
Q4 		$873K Sell
4,911
-79
-2% -$14.5K 0.34% 87
2024
Q3 		$969K Sell
4,990
-274
-5% -$51.1K 0.39% 92
2024
Q2 		$923K Buy
5,264
+226
+4% +$37.4K 0.36% 94
2024
Q1 		$917K Sell
5,038
-331
-6% -$57K 0.37% 80
2023
Q4 		$879K Sell
5,369
-140
-3% -$20.4K 0.38% 71
2023
Q3 		$800K Sell
5,509
-648
-11% -$95.1K 0.37% 63
2023
Q2 		$932K Buy
+6,157
New +$903K 0.41% 50
2023
Q1 		– Sell
-4,766
Closed -$770K – 68
2022
Q4 		$770K Sell
4,766
-527
-10% -$80.8K 0.42% 74
2022
Q3 		$778K Buy
5,293
+220
+4% +$31.6K 0.38% 63
2022
Q2 		$700K Sell
5,073
-2,347
-32% -$359K 0.32% 86
2022
Q1 		$1.29M Buy
+7,420
New +$1.08M 0.54% 40
2019
Q1 		– Sell
-3,541
Closed -$326K – 93
2018
Q4 		$326K Sell
3,541
-1,323
-27% -$116K 0.35% 70
2018
Q3 		$460K Sell
4,864
-48
-1% -$4.55K 0.3% 67
2018
Q2 		$455K Buy
4,912
+77
+2% +$7.52K 0.3% 62
2018
Q1 		$458K Sell
4,835
-33
-0.7% -$3.63K 0.32% 59
2017
Q4 		$471K Sell
4,868
-111
-2% -$10.5K 0.32% 62
2017
Q3 		$442K Buy
+4,979
New +$379K 0.32% 70

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Stableford Capital II's ABBV Position: Q2 2026 in Review

Stableford Capital II reduced its AbbVie (ABBV) stake by 5.7% in Q2 2026, selling an estimated $52.3K and leaving 4,031 shares worth $1.01M. The position accounts for 0.35% of the portfolio, ranked #79.

Stableford Capital II first reported a position in ABBV in Q3 2017 and has held it in 23 quarters since. The position peaked at $1.29M in Q1 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stableford Capital II held 4,031 shares of AbbVie worth $1.01M as of Q2 2026.
  • Stableford Capital II sold 243 AbbVie shares in Q2 2026, an estimated $52.3K.
  • AbbVie made up 0.35% of Stableford Capital II's portfolio in Q2 2026, its #79 holding.
  • Stableford Capital II first reported a position in AbbVie in Q3 2017 and has held it in 23 quarters since.
  • Stableford Capital II's AbbVie position peaked at $1.29M in Q1 2022.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stableford Capital II's 13F filing for Q2 2026, filed 6 Jul 2026.